Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 52

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 52
---
 may not engage in a business combination with an interested stockholder         
 for a period of three years after the time of the transaction in which the person became an interested stockholder. The prohibition      
 on business combinations with interested stockholders does not apply in some cases, including if: (i) the board of directors of the      
 corporation, prior to the time of the transaction in which the person became an interested stockholder, approves (a) the business        
 combination or (b) the transaction in which the stockholder becomes an interested stockholder; (ii) upon consummation of the transaction 
 which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting        
 stock of the corporation outstanding at the time the transaction commenced; or (iii) the board of directors and the holders of at        
 least two-thirds of the outstanding voting stock not owned by the interested stockholder approve the business combination on or after    
 the time of the transaction in which the person became an interested stockholder.                                                        
 For                                                                                                                                      
 the purpose of Section 203, the DGCL, subject to specified exceptions, generally defines an interested stockholder to include any        
 person who, together with that person’s affiliates or associates, (i) owns 15% or more of the outstanding voting stock of the            
 corporation (including any rights to acquire stock pursuant to an option, warrant, agreement, arrangement or understanding, or upon      
 the exercise of conversion or exchange rights, and stock with respect to which the person has voting rights only), or (ii) is an         
 affiliate or associate of the corporation and owned 15% or more of the outstanding voting stock of the corporation at any time within    
 the previous three years.                                                                                                                |     | The BCBCA does                                                                                       
 not contain a provision comparable to Section 203 of the DGCL with respect to business combinations. |

<div align='center'>13</div>

| Appraisal                                     
 Rights; Rights to Dissent                     |     | Under the DGCL,                                                                                                                          
 a stockholder of a corporation participating in some types of major corporate transactions may, under varying circumstances, be entitled 
 to appraisal rights pursuant to which the stockholder may receive cash in the amount of the fair market value of his or her shares       
 in lieu of the consideration he or she would otherwise receive in the transaction. For example, a stockholder is entitled to appraisal   
 rights in the case of a merger or consolidation if the shareholder is required to accept in exchange for the